| Literature DB >> 26315728 |
Rosario Fornaro1, Michela Caratto1, Ginevra Barbruni1, Francesco Fornaro1, Alexander Salerno1, Davide Giovinazzo1, Camilla Sticchi2, Elisa Caratto1.
Abstract
Ulcerative colitis (UC) is a chronic inflammatory disease of the mucosa of the colorectum. The treatment of UC depends on the severity of symptoms and the extent of the disease. Acute severe colitis (ASC) occurs in 12-25% of patients with UC. Patients with ASC must be managed by a multidisciplinary team. Medically or surgically aggressive treatment is carried out with the final aim of reducing mortality. Intravenous administration of corticosteroids is the mainstay of the therapy. Medical rescue therapy based on cyclosporine or infliximab should be considered if there is no response to corticosteroids for 3 days. If there has been no response to medical rescue therapy after 4-7 days, the patient must undergo colectomy in emergency surgery. Prolonged observation is counterproductive, as over time it increases the risk of toxic megacolon and perforation, with a very high mortality rate. The best potential treatment is subtotal colectomy with ileostomy and preservation of the rectum. Emergency surgery in UC should not be seen as a last chance, but can be considered as a life-saving procedure. Colectomies in emergency setting are characterized by high morbidity rates but the mortality is low.Entities:
Keywords: acute severe ulcerative colitis; corticosteroid; cyclosporin; inflammatory bowel disease; infliximab; surgical treatment
Mesh:
Substances:
Year: 2015 PMID: 26315728 DOI: 10.1111/1751-2980.12278
Source DB: PubMed Journal: J Dig Dis ISSN: 1751-2972 Impact factor: 2.325